BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 34015671)

  • 1. Facilitating SARS CoV-2 RNA-Dependent RNA polymerase (RdRp) drug discovery by the aid of HCV NS5B palm subdomain binders: In silico approaches and benchmarking.
    Elghoneimy LK; Ismail MI; Boeckler FM; Azzazy HME; Ibrahim TM
    Comput Biol Med; 2021 Jul; 134():104468. PubMed ID: 34015671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supporting SARS-CoV-2 Papain-Like Protease Drug Discovery:
    Ibrahim TM; Ismail MI; Bauer MR; Bekhit AA; Boeckler FM
    Front Chem; 2020; 8():592289. PubMed ID: 33251185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plant-derived natural polyphenols as potential antiviral drugs against SARS-CoV-2
    Singh S; Sk MF; Sonawane A; Kar P; Sadhukhan S
    J Biomol Struct Dyn; 2021 Oct; 39(16):6249-6264. PubMed ID: 32720577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) with synthetic/designer unnatural nucleoside analogs: an in silico study.
    Bag SS; Sinha S; Dutta S; Baishya HJ; Paul S
    J Mol Model; 2023 Nov; 29(12):366. PubMed ID: 37950101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
    Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Hassan HHA; Ismail MI; Abourehab MAS; Boeckler FM; Ibrahim TM; Arafa RK
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 RNA dependent RNA polymerase (RdRp) targeting: an
    Elfiky AA
    J Biomol Struct Dyn; 2021 Jun; 39(9):3204-3212. PubMed ID: 32338164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying non-nucleoside inhibitors of RNA-dependent RNA-polymerase of SARS-CoV-2 through per-residue energy decomposition-based pharmacophore modeling, molecular docking, and molecular dynamics simulation.
    Aziz S; Waqas M; Mohanta TK; Halim SA; Iqbal A; Ali A; Khalid A; Abdalla AN; Khan A; Al-Harrasi A
    J Infect Public Health; 2023 Apr; 16(4):501-519. PubMed ID: 36801630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Denovo designing, retro-combinatorial synthesis, and molecular dynamics analysis identify novel antiviral VTRM1.1 against RNA-dependent RNA polymerase of SARS CoV2 virus.
    Tiwari V
    Int J Biol Macromol; 2021 Feb; 171():358-365. PubMed ID: 33421473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of turmeric-derived compounds against RNA-dependent RNA polymerase of SARS-CoV-2: An in-silico approach.
    Singh R; Bhardwaj VK; Purohit R
    Comput Biol Med; 2021 Dec; 139():104965. PubMed ID: 34717229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repositioning Therapeutics for SARS-CoV-2: Virtual Screening of Plant-based Anti-HIV Compounds as Possible Inhibitors against COVID-19 Viral RdRp.
    Murali M; Gowtham HG; Ansari MA; Alomary MN; Alghamdi S; Almehmadi M; Singh SB; Shilpa N; Aiyaz M; Kalegowda N; Ledesma AE; Amruthesh KN
    Curr Pharm Des; 2022; 28(12):969-980. PubMed ID: 35796443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-HCV, Sofosbuvir, versus the anti-EBOV Remdesivir against SARS-CoV-2 RNA dependent RNA polymerase in silico.
    Elfiky AA; Azzam EB; Shafaa MW
    Mol Divers; 2022 Feb; 26(1):171-181. PubMed ID: 33389441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacophore screening to identify natural origin compounds to target RNA-dependent RNA polymerase (RdRp) of SARS-CoV2.
    Mishra A; Rathore AS
    Mol Divers; 2022 Oct; 26(5):2613-2629. PubMed ID: 35000060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A computational approach to drug repurposing against SARS-CoV-2 RNA dependent RNA polymerase (RdRp).
    Ribaudo G; Ongaro A; Oselladore E; Zagotto G; Memo M; Gianoncelli A
    J Biomol Struct Dyn; 2022 Feb; 40(3):1101-1108. PubMed ID: 32948103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach.
    Aftab SO; Ghouri MZ; Masood MU; Haider Z; Khan Z; Ahmad A; Munawar N
    J Transl Med; 2020 Jul; 18(1):275. PubMed ID: 32635935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural Insights into the Binding Modes of Viral RNA-Dependent RNA Polymerases Using a Function-Site Interaction Fingerprint Method for RNA Virus Drug Discovery.
    Zhao Z; Bourne PE
    J Proteome Res; 2020 Nov; 19(11):4698-4705. PubMed ID: 32946692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of monoclonal antibodies that specifically recognize the palm subdomain of hepatitis C virus nonstructural protein 5B polymerase.
    Ingravallo P; Lahser F; Xia E; Sodowich B; Lai VC; Hong Z; Zhong W
    Virus Res; 2001 Jun; 75(2):179-87. PubMed ID: 11325472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Small-Molecule Inhibitors of SARS-CoV-2 RNA-Dependent RNA Polymerase by Establishing a Fluorometric Assay.
    Bai X; Sun H; Wu S; Li Y; Wang L; Hong B
    Front Immunol; 2022; 13():844749. PubMed ID: 35464436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase.
    Zhang L; Zhou R
    J Phys Chem B; 2020 Aug; 124(32):6955-6962. PubMed ID: 32521159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer-assisted drug discovery of potential natural inhibitors of the SARS-CoV-2 RNA-dependent RNA polymerase through a multi-phase
    Elkaeed EB; Alsfouk BA; Ibrahim TH; Arafa RK; Elkady H; Ibrahim IM; Eissa IH; Metwaly AM
    Antivir Ther; 2023 Oct; 28(5):13596535231199838. PubMed ID: 37669909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.